Skip to main content

Table 3 Summary of previous screening studies of the G2019S mutation in the Tunisian population

From: Using KASP technique to screen LRRK2 G2019S mutation in a large Tunisian cohort

Reference Type of study Frequency in patients (%) Frequency in controls (%)
Ishihara et al. 2007 [13] Familial 38/91 (42%) ND a
Hulihan et al. 2008 [15] Unrelated patients 72/238 (30%) 7/371(2%)
Trinh et al. 2014 [16] Unrelated patients
Related patients
220/570 (38%)
126/288 (45%)
12/580 (3%)
The present study Unrelated patients 84/250 (33.6%) 3/218 (1.3%)
  1. a ND not defined